Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

22.07.2024

9 Ann Intern Med
7 Antiviral Res
1 Biochem Biophys Res Commun
2 BMC Pediatr
10 BMJ
2 Eur J Epidemiol
1 J Clin Microbiol
2 J Exp Med
12 J Infect
1 J Infect Dis
1 JAMA
2 N Engl J Med
1 PLoS Med
25 PLoS One
3 Proc Natl Acad Sci U S A
10 Vaccine
4 Virology


    Ann Intern Med

  1. FUJIEDA T, Tanimoto T
    Communicating the Value of Influenza Vaccines to Patients.
    Ann Intern Med. 2024;177:990-991.
    >> Share

  2. SCHATTNER A
    Communicating the Value of Influenza Vaccines to Patients.
    Ann Intern Med. 2024;177:990.
    >> Share

  3. TENFORDE MW, Dawood FS
    Communicating the Value of Influenza Vaccines to Patients.
    Ann Intern Med. 2024;177:991.
    >> Share

  4. KAUFFMAN RP
    mRNA COVID-19 vaccination during pregnancy was not linked to increased adverse neonatal outcomes.
    Ann Intern Med. 2024 Jul 2. doi: 10.7326/ANNALS-24-00621.
    >> Share

  5. SWEENEY DA, Kalil AC
    In adults with COVID-19 and severe hypoxemia, lower vs. higher oxygenation targets increased days alive without life support.
    Ann Intern Med. 2024 Jul 2. doi: 10.7326/ANNALS-24-00558.
    >> Share

  6. DUTCHER EG, Epel ES, Mason AE, Hecht FM, et al
    COVID-19 Vaccine Side Effects and Long-Term Neutralizing Antibody Response : A Prospective Cohort Study.
    Ann Intern Med. 2024 Jun 11. doi: 10.7326/M23-2956.
    >> Share

  7. CHOU R, Herman E, Ahmed A, Anderson J, et al
    Long COVID Definitions and Models of Care : A Scoping Review.
    Ann Intern Med. 2024;177:929-940.
    >> Share


  8. Annals Video Summary - Long COVID Definitions and Models of Care: A Scoping Review.
    Ann Intern Med. 2024;177:eM240874.
    >> Share

  9. BRODE WM
    Long COVID: The Enduring Pandemic.
    Ann Intern Med. 2024;177:978-979.
    >> Share


    Antiviral Res

  10. DICKEY TH, Salinas ND, Patel P, Orr-Gonzalez S, et al
    RBD design increases the functional antibody titers elicited by SARS-CoV-2 spike vaccination.
    Antiviral Res. 2024 Jun 18:105937. doi: 10.1016/j.antiviral.2024.105937.
    >> Share

  11. LIU X, Zheng M, Zhang H, Feng B, et al
    Characterization and noncovalent inhibition of the K63-deubiquitinase activity of SARS-CoV-2 PLpro.
    Antiviral Res. 2024 Jun 22:105944. doi: 10.1016/j.antiviral.2024.105944.
    >> Share

  12. BALIGA-GIL A, Soszynska-Jozwiak M, Ruszkowska A, Szczesniak I, et al
    Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication.
    Antiviral Res. 2024 Jun 24:105946. doi: 10.1016/j.antiviral.2024.105946.
    >> Share

  13. DANIELS A, Padariya M, Fletcher S, Ball K, et al
    Molecules targeting a novel homotrimer cavity of Spike protein attenuate replication of SARS-CoV-2.
    Antiviral Res. 2024;228:105949.
    >> Share

  14. WILLIAMS N, Silva F, Schmolke M
    Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy.
    Antiviral Res. 2024 Jun 28:105951. doi: 10.1016/j.antiviral.2024.105951.
    >> Share

  15. CHEN D, Su W, Choy KT, Chu YS, et al
    High throughput profiling identified PA-L106R amino acid substitution in A(H1N1)pdm09 influenza virus that confers reduced susceptibility to baloxavir in vitro.
    Antiviral Res. 2024 Jul 11:105961. doi: 10.1016/j.antiviral.2024.105961.
    >> Share

  16. VAN LOY B, Stevaert A, Naesens L
    The coronavirus nsp15 endoribonuclease: a puzzling protein and pertinent antiviral drug target.
    Antiviral Res. 2024 May 31:105921. doi: 10.1016/j.antiviral.2024.105921.
    >> Share


    Biochem Biophys Res Commun

  17. KUSHWAHA N, Dwivedi A, Tiwari S, Mishra P, et al
    Comprehensive analytics for virus-cell and cell-cell multinucleation system.
    Biochem Biophys Res Commun. 2024;726:150281.
    >> Share


    BMC Pediatr

  18. JING JQ, Yang CJ, Wang Y, Su XY, et al
    Impact of COVID-19 on emotional and behavioral problems among preschool children: a meta-analysis.
    BMC Pediatr. 2024;24:455.
    >> Share

  19. MAO S, Wu L
    Coinfection of viruses in children with community-acquired pneumonia.
    BMC Pediatr. 2024;24:457.
    >> Share


    BMJ

  20. IACOBUCCI G
    Sixty seconds on . . . nasal sprays.
    BMJ. 2024;386:q1560.
    >> Share

  21. IACOBUCCI G
    Childhood immunisation: Global rates remain below pre-pandemic levels.
    BMJ. 2024;386:q1577.
    >> Share

  22. WISE J
    Covid-19: Progression to clinical type 1 diabetes accelerated after infection, study suggests.
    BMJ. 2024;386:q1557.
    >> Share

  23. MAGNUS MC, Soderling J, Ortqvist AK, Andersen AN, et al
    Covid-19 infection and vaccination during first trimester and risk of congenital anomalies: Nordic registry based study.
    BMJ. 2024;386:e079364.
    >> Share

  24. LIMB M
    King's speech: Health leaders laud commitments on public and mental health as "game changing".
    BMJ. 2024;386:q1590.
    >> Share

  25. MAHASE E
    GPs in Wales need "urgent rescue package" after 100 practices close, says BMA.
    BMJ. 2024;386:q1589.
    >> Share

  26. MAHASE E
    Covid inquiry: UK government failed its citizens through "groupthink," poor planning, and widening inequalities.
    BMJ. 2024;386:q1602.
    >> Share


  27. Seven days in medicine: 10-16 July 2024.
    BMJ. 2024;386:q1566.
    >> Share

  28. MAHASE E
    GP appointment and patient record system disrupted by global IT outage.
    BMJ. 2024;386:q1617.
    >> Share

  29. LIMB M
    Paying care workers properly could cost pound40bn but would lead to NHS savings, says strategy.
    BMJ. 2024;386:q1608.
    >> Share


    Eur J Epidemiol

  30. MEYER AC, Ebeling M, Acosta E, Modig K, et al
    Continued decline in the incidence of myocardial infarction beyond the COVID-19 pandemic: a nationwide study of the Swedish population aged 60 and older during 2015-2022.
    Eur J Epidemiol. 2024;39:605-612.
    >> Share

  31. AUGER N, Arbour L, Lewin A, Brousseau E, et al
    Congenital anomalies during Covid-19: artifact of surveillance or a real TORCH?
    Eur J Epidemiol. 2024;39:613-621.
    >> Share


    J Clin Microbiol

  32. YAMAMOTO H, Tamura T, Ichikawa T, Taguchi Y, et al
    Generation of recombinant viruses directly from clinical specimens of COVID-19 patients.
    J Clin Microbiol. 2024;62:e0004224.
    >> Share


    J Exp Med

  33. CHAN YH, Lundberg V, Le Pen J, Yuan J, et al
    SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency.
    J Exp Med. 2024;221:e20231725.
    >> Share

  34. FERNBACH S, Mair NK, Abela IA, Groen K, et al
    Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies.
    J Exp Med. 2024;221:e20240365.
    >> Share


    J Infect

  35. CLARK SA, Campbell H, Ribeiro S, Bertran M, et al
    Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in England.
    J Infect. 2023 Sep 7:S0163-4453(23)00504-2. doi: 10.1016/j.jinf.2023.
    >> Share

  36. ALPIZAR SA, Accini J, Anderson DC, Eysa B, et al
    Molnupiravir for Intra-Household Prevention of COVID-19: the MOVe-AHEAD Randomized, Placebo-Controlled Trial.
    J Infect. 2023 Sep 8:S0163-4453(23)00500-5. doi: 10.1016/j.jinf.2023.
    >> Share

  37. JIANG J, Li Y, Jiang Q, Jiang Y, et al
    Early use of oral antiviral drugs and the risk of post COVID-19 syndrome: a systematic review and network meta-analysis.
    J Infect. 2024 Jun 2:106190. doi: 10.1016/j.jinf.2024.106190.
    >> Share

  38. MIKOLAJCZYK R, Diexer S, Klee B, Pfrommer L, et al
    Likelihood of Post-COVID Condition in people with hybrid immunity; data from the German National Cohort (NAKO).
    J Infect. 2024 Jun 17:106206. doi: 10.1016/j.jinf.2024.106206.
    >> Share

  39. KAJIHARA T, Yahara K, Kamigaki T, Hirabayashi A, et al
    Effects of coronavirus disease 2019 on the spread of respiratory-transmitted human-to-human bacteria.
    J Infect. 2024 Jun 17:106201. doi: 10.1016/j.jinf.2024.106201.
    >> Share

  40. LIU B, Xu L, Ma Y, Wang H, et al
    Evidence of immunity gap: Decline in antibodies against M. pneumoniae during the COVID-19 pandemic.
    J Infect. 2024 Jun 18:106209. doi: 10.1016/j.jinf.2024.106209.
    >> Share

  41. PEREZ-GARCIA C, Sempere J, de Miguel S, Hita S, et al
    Surveillance of invasive pneumococcal disease in Spain exploring the impact of the COVID-19 pandemic (2019-2023).
    J Infect. 2024;89:106204.
    >> Share

  42. GONG X, Peng L, Wang F, Liu J, et al
    Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variants.
    J Infect. 2024;89:106208.
    >> Share

  43. CHAKA A, Pan D, Irshad M, Piranie H, et al
    Inclusion of racial and ethnic groups in clinical trials for COVID-19 and post-acute COVID-19 syndrome: an analysis of studies registered on ClinicalTrials.gov.
    J Infect. 2024 Jun 20:106207. doi: 10.1016/j.jinf.2024.106207.
    >> Share

  44. DU Z, Wang S, Chen R, Shan S, et al
    Efficacy and safety of respiratory syncytial virus prefusion F protein vaccines in adults.
    J Infect. 2024;89:106211.
    >> Share

  45. BOYS R, Plank J, Bird P, Fletcher O, et al
    Impact of COVID-19 restrictions on the incidence of respiratory viruses in two British Antarctic Survey bases.
    J Infect. 2024;89:106196.
    >> Share

  46. BOOM TT, de Hoog MLA, Westerhof I, Jaddoe V, et al
    Age-specific SARS-CoV-2 transmission differed from human rhinovirus in households during the early COVID-19 pandemic.
    J Infect. 2024 Jun 29:106218. doi: 10.1016/j.jinf.2024.106218.
    >> Share


    J Infect Dis

  47. HILL-BATORSKI L, Weiner JA, Ackerman ME, Hatta Y, et al
    Intranasal M2SR (M2-deficient Single Replication) Influenza Vaccine Induces Broadly Reactive Mucosal Antibody Production in Adults.
    J Infect Dis. 2024 Jul 16:jiae361. doi: 10.1093.
    >> Share


    JAMA

  48. ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al
    Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults.
    JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673.
    >> Share


    N Engl J Med

  49. HAMMOND J, Yunis C, Fountaine RJ, Luscan G, et al
    Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19.
    N Engl J Med. 2024;391:224-234.
    >> Share

  50. MEISSNER HC, Kapogiannis BG, Wolfe DN
    Anticipating the Next Pandemic.
    N Engl J Med. 2024;391:196-199.
    >> Share


    PLoS Med

  51. SAMUEL M, Park RY, Eastwood SV, Eto F, et al
    Trends in weight gain recorded in English primary care before and during the Coronavirus-19 pandemic: An observational cohort study using the OpenSAFELY platform.
    PLoS Med. 2024;21:e1004398.
    >> Share


    PLoS One

  52. LOISEAU A, Davit-Beal T, Brezulier D
    Are protective measures against Covid-19 still active in orthodontic practices? A cross-sectional online survey of French orthodontists three years on from the pandemic.
    PLoS One. 2024;19:e0307453.
    >> Share

  53. IFEAGWU SC, Nakaboga Kikonyogo R, Nakkazi S, Beinomugisha J, et al
    "Sickness has no time": Awareness and perceptions of health care workers on universal health coverage in Uganda.
    PLoS One. 2024;19:e0306922.
    >> Share

  54. MASHININI DP, Kelly NK, Mataboge P, Hill F, et al
    COVID-19-related stigma within a rural South African community: A mixed methods analysis.
    PLoS One. 2024;19:e0306821.
    >> Share

  55. ALAMIN MH, Rahaman MM, Ferdousi F, Sarker A, et al
    In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing.
    PLoS One. 2024;19:e0304425.
    >> Share

  56. NOWROUZI-KIA B, Haritos AM, Long BS, Atikian C, et al
    Remote work transition amidst COVID-19: Impacts on presenteeism, absenteeism, and worker well-being-A scoping review.
    PLoS One. 2024;19:e0307087.
    >> Share

  57. DLANGALALA T, Musekiwa A, Mashamba-Thompson T
    Quality of TB diagnostic services at primary healthcare clinics in eThekwini district, South Africa.
    PLoS One. 2024;19:e0307149.
    >> Share

  58. ROTH AM, Ward KM, Hensel DJ, Elliott L, et al
    Exploration of weekly variation in naloxone possession and carriage among people who use opioids in New York City before, during, and after the COVID-19 pandemic.
    PLoS One. 2024;19:e0307151.
    >> Share

  59. QUEE FA, Hogema BM, Molier M, Slot E, et al
    The Elecsys(R) Anti-SARS-CoV-2 and Elecsys(R) Anti-SARS-CoV-2 S antibody assays: Differentiating between vaccination and infection, and assessing long-term performance.
    PLoS One. 2024;19:e0305613.
    >> Share

  60. AMEDEWONU EA, Aryeetey GC, Godi A, Sackeyfio J, et al
    Assessment of the quality of life of COVID-19 recovered patients at the Ghana Infectious Disease Centre.
    PLoS One. 2024;19:e0306118.
    >> Share

  61. MURNI IK, Oktaria V, McCarthy DT, Supriyati E, et al
    Wastewater-based epidemiology surveillance as an early warning system for SARS-CoV-2 in Indonesia.
    PLoS One. 2024;19:e0307364.
    >> Share

  62. FLOUD S, Hermon C, Reeves GK
    Physical and mental health of 40,000 older women in England during the COVID-19 pandemic (2020-2021).
    PLoS One. 2024;19:e0307106.
    >> Share

  63. KALBUS AI, Cornelsen L, Ballatore A, Cummins S, et al
    Associations between the neighbourhood food environment and food and drink purchasing in England during lockdown: A repeated cross-sectional analysis.
    PLoS One. 2024;19:e0305295.
    >> Share

  64. UTUNEN H, Balaciano G, Arabi E, Tokar A, et al
    Learning interventions and training methods in health emergencies: A scoping review.
    PLoS One. 2024;19:e0290208.
    >> Share


  65. Retraction: Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs.
    PLoS One. 2024;19:e0307483.
    >> Share

  66. FIHEL A, Janicka A, Buschner A, Ustinaviciene R, et al
    Unrecognised COVID-19 deaths in central Europe: The importance of cause-of-death certification for the COVID-19 burden assessment.
    PLoS One. 2024;19:e0307194.
    >> Share

  67. BELL CF, Gibbons DC, Drysdale M, Birch HJ, et al
    Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic electronic health records.
    PLoS One. 2024;19:e0304822.
    >> Share

  68. LEE J, Lee CW, Suarez DL, Lee SA, et al
    Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens.
    PLoS One. 2024;19:e0307100.
    >> Share

  69. ZHU X, Zhang Y, Ying H, Chi H, et al
    Modeling epidemic dynamics using Graph Attention based Spatial Temporal networks.
    PLoS One. 2024;19:e0307159.
    >> Share

  70. WYNBERG E, Han AX, van Willigen HDG, Verveen A, et al
    Inflammatory profiles are associated with long COVID up to 6 months after COVID-19 onset: A prospective cohort study of individuals with mild to critical COVID-19.
    PLoS One. 2024;19:e0304990.
    >> Share

  71. DE SA LEITAO CS, Dos Santos CHDA, Valente J, Maia B, et al
    Amazon tropical fishes of commercial interest show human-cell contamination but no SARS-CoV-2 in a real-life scenario.
    PLoS One. 2024;19:e0306985.
    >> Share

  72. HUYNH J, Phan TMH
    Uncertainty in banking and debt financing of firms in Vietnam.
    PLoS One. 2024;19:e0305724.
    >> Share

  73. FERREIRA RA, Fassarella CS, Ribeiro OMPL, Cardoso RB, et al
    Safety climate in the operating room in the pre-pandemic and pandemic period of COVID-19: A mixed method study.
    PLoS One. 2024;19:e0305281.
    >> Share

  74. MEHTA KJ, Aula-Blasco J, Mantaj J
    University students' preferences of learning modes post COVID-19-associated lockdowns: In-person, online, and blended.
    PLoS One. 2024;19:e0296670.
    >> Share

  75. ABDULAI K, Alhassan AR, Aleboko SO, Ahmed MD, et al
    Dietary diversity and nutritional status of adults living with HIV during the COVID-19 era.
    PLoS One. 2024;19:e0307427.
    >> Share

  76. KARIMI M, Khami MR, Varmazyari S, Shamshiri AR, et al
    COVID-19's psychological toll on oral health: A cross-sectional study in Iranian adults.
    PLoS One. 2024;19:e0307429.
    >> Share


    Proc Natl Acad Sci U S A

  77. LEIBEL SL, McVicar RN, Murad R, Kwong EM, et al
    A therapy for suppressing canonical and noncanonical SARS-CoV-2 viral entry and an intrinsic intrapulmonary inflammatory response.
    Proc Natl Acad Sci U S A. 2024;121:e2408109121.
    >> Share

  78. ROACH SN, Shepherd FK, Mickelson CK, Fiege JK, et al
    Tropism for ciliated cells is the dominant driver of influenza viral burst size in the human airway.
    Proc Natl Acad Sci U S A. 2024;121:e2320303121.
    >> Share

  79. GUARNIERI JW, Lie T, Albrecht YES, Hewin P, et al
    Mitochondrial antioxidants abate SARS-COV-2 pathology in mice.
    Proc Natl Acad Sci U S A. 2024;121:e2321972121.
    >> Share


    Vaccine

  80. CERNUSCHI T, Malvolti S, Hall S, Debruyne L, et al
    The quest for more effective vaccine markets - Opportunities, challenges, and what has changed with the SARS-CoV-2 pandemic.
    Vaccine. 2024;42 Suppl 1:S64-S72.
    >> Share

  81. SAXENIAN H, Alkenbrack S, Freitas Attaran M, Barcarolo J, et al
    Sustainable financing for Immunization Agenda 2030.
    Vaccine. 2024;42 Suppl 1:S73-S81.
    >> Share

  82. BLANC DC, Grundy J, Sodha SV, O'Connell TS, et al
    Immunization programs to support primary health care and achieve universal health coverage.
    Vaccine. 2024;42 Suppl 1:S38-S42.
    >> Share

  83. WALLACE AS, Ryman TK, Privor-Dumm L, Morgan C, et al
    Leaving no one behind: Defining and implementing an integrated life course approach to vaccination across the next decade as part of the immunization Agenda 2030.
    Vaccine. 2022 Dec 8:S0264-410X(22)01452-9. doi: 10.1016/j.vaccine.2022.
    >> Share

  84. OLAYINKA F, Sauer M, Menning L, Summers D, et al
    Building and sustaining public and political commitment to the value of vaccination: Recommendations for the Immunization Agenda 2030 (Strategic Priority Area 2).
    Vaccine. 2022 Dec 15:S0264-410X(22)01451-7. doi: 10.1016/j.vaccine.2022.
    >> Share

  85. ZHU J, Cole CB, Fihman J, Adjagba A, et al
    Opportunities to accelerate immunization progress in middle-income countries.
    Vaccine. 2024;42 Suppl 1:S98-S106.
    >> Share


  86. Immunization agenda 2030: A global strategy to leave no one behind.
    Vaccine. 2024;42 Suppl 1:S5-S14.
    >> Share

  87. ERIKSSON M, Nylen S, Gronvik KO
    Passive immunization of mice with IgY anti-H5N1 protects against experimental influenza virus infection and allows development of protective immunity.
    Vaccine. 2024 Jul 16:S0264-410X(24)00796-5. doi: 10.1016/j.vaccine.2024.
    >> Share

  88. LIU G, Pang Y, Lv M, Lu M, et al
    Effectiveness of influenza vaccination on hospitalization outcomes among older patients with diabetes.
    Vaccine. 2024 Jul 16:S0264-410X(24)00806-5. doi: 10.1016/j.vaccine.2024.
    >> Share

  89. SANTIBANEZ TA, Black CL, Zhou T, Srivastav A, et al
    Parental hesitancy about COVID-19, influenza, HPV, and other childhood vaccines.
    Vaccine. 2024 Jul 16:S0264-410X(24)00802-8. doi: 10.1016/j.vaccine.2024.
    >> Share


    Virology

  90. CAI M, Wei Z, Hu X, Ji Y, et al
    The evolution, complexity, and diversity of swine influenza viruses in China: A hidden public health threat.
    Virology. 2024;598:110167.
    >> Share

  91. LEI Y, Xu N, Niu C, Chen L, et al
    Specific immunological characteristics and risk factor of XBB variants re-infection in nasopharyngeal carcinoma patients after BA.5 infection.
    Virology. 2024;597:110142.
    >> Share

  92. LIANG Z, Wang J, Zhang H, Gao L, et al
    Peptide S4 is an entry inhibitor of SARS-CoV-2 infection.
    Virology. 2024;597:110149.
    >> Share

  93. DUDEK I, Czerkies M, Kwiatek A
    Differential expression of cytokines and elevated levels of MALAT1 - Long non-coding RNA in response to non-structural proteins of human respiratory syncytial virus.
    Virology. 2024;597:110127.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016